scispace - formally typeset
M

Malachy Ifeanyi Okeke

Researcher at American University of Nigeria

Publications -  28
Citations -  1190

Malachy Ifeanyi Okeke is an academic researcher from American University of Nigeria. The author has contributed to research in topics: Medicine & Orthopoxvirus. The author has an hindex of 11, co-authored 20 publications receiving 650 citations. Previous affiliations of Malachy Ifeanyi Okeke include University of Nigeria, Nsukka & University of Tromsø.

Papers
More filters
Journal ArticleDOI

Monkeypox Virus in Nigeria: Infection Biology, Epidemiology, and Evolution.

TL;DR: This review X-rays the current state of knowledge pertaining to the infection biology, epidemiology, and evolution of MPXV in Nigeria and worldwide, especially with regard to the human, cellular, and viral factors that modulate the virus transmission dynamics, infection, and its maintenance in nature.
Journal ArticleDOI

Evaluation of extracts of the root of Landolphia owerrience for antibacterial activity

TL;DR: The strong activity of the ethanolic extracts against known etiologic agents of diseases traditionally treated with L. owerrience root of similar preparations provides scientific justification for the use of the herb in ethnomedical practice in Nigeria.
Journal ArticleDOI

Antibacterial activity of Harungana madagascariensis leaf extracts.

TL;DR: The results provide a rationalization for the traditional use of H. madagascariensis leaf extracts for the treatment of gastrointestinal disorders.
Journal ArticleDOI

Monkeypox virus: a neglected zoonotic pathogen spreads globally

TL;DR: The ongoing monkeypox outbreak in non-endemic countries is likely to be a consequence of the failure to curtail the spread of the disease in endemic regions of Africa despite decades of constant outbreaks as discussed by the authors .
Journal ArticleDOI

Modified vaccinia virus Ankara multiplies in rat IEC-6 cells and limited production of mature virions occurs in other mammalian cell lines.

TL;DR: The multiplication and morphogenesis of a recombinant (MVA-HANP) and non-recombinant MVA strain in BHK-21 and 12 other mammalian cell lines have now been compared and are relevant to the production and biosafety of MVA-vectored vaccines.